The evaluation of Recombinant Immunoblot assay (RIBA) and HCV-RNA test results in patients with low titer Anti-HCV positivity

The evaluation of Recombinant Immunoblot assay (RIBA) and HCV-RNA test results in patients with low titer Anti-HCV positivity

Objectives: Laboratory diagnosis of hepatitis C virus (HCV) infection is based on the detection of anti-HCV antibodies by enzyme immunoassay (EIA) or chemiluminescence immunoassay (CIA) techniques. However, a consensus related to the problem of low titer (Serum/Cut-off; S/C= 1.0) anti-HCV antibodie...

Full description

Bibliographic Details
Main Authors:	Berrin Uzun, Hakan Er, Serdar Güngör, A. Gamze Şener, Selçuk Kaya
Format:	Article
Language:	English
Published:	Modestum Publishing LTD 2014-12-01
Series:	Journal of Clinical and Experimental Investigations
Subjects:	Anti-HCV HCV RNA Hepatitis C virus S/C ratio
Online Access:	http://www.jceionline.org/upload/sayi/25/JCEI-01021.pdf

Similar Items

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
by: Rujipat Wasitthankasem, et al.
Published: (2017-11-01)

Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors
by: Felicidade Mota Pereira, et al.
Published: (2014-01-01)

HCV Seroreactivity and Detection of HCV RNA in Hepatitis Cases
by: Mahantesh B Nagamoti, et al.
Published: (2018-04-01)

Circumstances of infection with HCV in selected Polish provinces
by: Lidia Sierpińska
Published: (2021-02-01)

Prevalence and characteristics of hepatitis C virus infection in Shenyang City, Northeast China, and prediction of HCV RNA positivity according to serum anti-HCV level: retrospective review of hospital data
by: Yurong Li, et al.
Published: (2020-03-01)

Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
by: Truong Tam Nguyen, et al.
Published: (2018-12-01)

How are HCV-infected patients being identified in Brazil: a multicenter study
by: Luiz H. Portari-Filho, et al.
Published: (2019-05-01)

Genotyping of hepatitis C virus (HCV) in infected patients from Northeast Mexico
by: Ana María Rivas-Estilla, et al.
Published: (2008-04-01)

The Case of anti-HCV Negative Chronic Hepatitis C
by: A. L. Rossina, et al.
Published: (2015-12-01)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
by: Claudia Minosse, et al.
Published: (2021-06-01)

Seroprevalence of HBV and HCV markers among young adult males in the Air Force in Florianópolis, South Brazil
by: Ana Maria Passos, et al.
Published: (2012-06-01)

Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community
by: Wei-Ming Chen, et al.
Published: (2021-05-01)

Study of Various HCV Genotypes in Patients Managing by Referral Clinic in Yazd Province
by: M Pedarzadeh, et al.
Published: (2012-02-01)

Hepatitis c virus(HCV) genotyping detection methods and its clinical significance
by: Tian Geng
Published: (2016-08-01)

Detection rate of specific antibodies to the HCV CORE+1 protein in “naive” cronically HCV-infected patients in depends on the stage of liver fibrosis and the HCV subtype
by: E. V. Lichnaya, et al.
Published: (2021-01-01)

An Audit Study of the Changes in Hepatitis C Virus (HCV) Testing Services among Labtests, Northland Pathology Laboratory and LabPLUS in New Zealand
by: Kim, Joeun
Published: (2018)

Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
by: K Samimi-rad, et al.
Published: (2008-09-01)

Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
by: K Samimi-rad, et al.
Published: (2008-09-01)

Circulation of an atypical hepatitis C virus (HCV) strain at a dialysis unit in northeast India
by: Deepjyoti Kalita, et al.
Published: (2021-02-01)

Detection of hepatitis C virus RNA in saliva samples from patients with seric anti-HCV antibodies
by: Patrícia L. Gonçalves, et al.

HCV infection prevalence in a population recruited at health centers in Jordan
by: Waseem Hamoudi, et al.
Published: (2019-04-01)

Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension
by: Babita Agrawal, et al.
Published: (2017-07-01)

Anti-HCV prevalence and risk factors analysis in pregnant women in central Brazil
by: Regina M. B Martins, et al.
Published: (1995-02-01)

Seropositivity of HBsAg, anti-HCV and anti-HIV in preoperative patients
by: Berrin Karaayak Uzun, et al.
Published: (2014-12-01)

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection
by: Óscar Brochado-Kith, et al.
Published: (2019-06-01)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
by: Ashfaq Usman Alli A, et al.
Published: (2011-06-01)

Comparative studies in detection of anti-HCV antibodies using Abbott IMx HCV, Serodia-HCV and DETECT-HCVTM
by: Nisarat Apichartpiyakul, et al.
Published: (2010-01-01)

Characterization of Host Protein Interactions with HCV RNA : Implications in Viral Translation, Replication and Design of Antivirals
by: Bhat, Prasanna
Published: (2018)

Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients
by: Paolucci Stefania, et al.
Published: (2012-10-01)

Clinical Findings of HCV Chronic Infection in Undocumented Immigrants and Low-Income Refugees in Three Areas of Southern Italy
by: Evangelista Sagnelli, et al.
Published: (2018-01-01)

Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
by: El-Shenawy Reem, et al.
Published: (2011-08-01)

The Distribution of Hepatitis C Virus (HCV) Genotypes in 59 HCV Infected Patients: A Multicenter Study
by: Emine SÖNMEZ, et al.
Published: (1996-06-01)

Clinical and epidemiological features of chronic hepatitis C in the north-western region of Ukraine
by: T. I. Bevz
Published: (2020-02-01)

NK cell function and receptor diversity in the context of HCV infection
by: Clair M Gardiner
Published: (2015-09-01)

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
by: Marzieh Jamalidoust, et al.
Published: (2017-07-01)

A clinical, epidemological, laboratorial, histological and ultrasonographical evaluation of anti-HCV EIA-2 positive blood donors Avaliação clínica, epidemiológica, laboratorial, histológica e ultrassonográfica de doadores de sangue anti-HCV EIA-2 positivos
by: Fernando L. GONÇALES JR, et al.
Published: (2000-06-01)

Hepatitis C Virus Serologic and Virologic Tests and Clinical Diagnosis of HCV-Related Liver Disease
Published: (2006-04-01)

Experimental models for hepatitis C virus (HCV): New opportunities for combating hepatitis C
by: Karina del Carmen Trujillo-Murillo, Ph.D., et al.
Published: (2004-04-01)

Humanized-VHH Transbodies that Inhibit HCV Protease and Replication
by: Surasak Jittavisutthikul, et al.
Published: (2015-04-01)

Immunopotentiating and Delivery Systems for HCV Vaccines
by: Alexander K. Andrianov, et al.
Published: (2021-05-01)